Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2
This phase II/III Lung-MAP trial studies how well immunotherapy treatment w...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
PHASE1
A Phase Ib/II, open label, multi-center, randomized study designed to asses...